Results 111 to 120 of about 15,879 (168)

Testosterone Replacement in Prostate Carcinoma: A Systematic Review of an Emerging Paradigm and Therapeutic Potential. [PDF]

Cureus
Robinson J, Banerjee I, Banerjee I.
europepmc   +1 more source

Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs). [PDF]

Gene
Pederzoli F, Pakula H, Rodrigues S, Garner R, Nuzzo PV, Bleve S, Rickman DS, Fanelli GN, Loda M.   +8 more
europepmc   +1 more source

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). [PDF]

J Immunother Cancer
Kyriakopoulos CE, Pachynski RK, Eickhoff JC, Tonelli TP, Jeon D, McNeel DG.   +5 more
europepmc   +1 more source

Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study. [PDF]

Sci Rep
Wänman J, Farhang M, Nyström H, Styrke J, Häggström C, Stattin P, Crnalic S.   +6 more
europepmc   +1 more source

Neuroendocrine Transformation Without PSA Elevation in High-Risk Metastatic Castration-Sensitive Prostate Cancer Under Androgen Receptor Signaling Inhibition: A Case Report. [PDF]

IJU Case Rep
Nakagami Y, Ohnuma S, Tamaoka M, Inoue T, Yamagishi M, Oshinomi K, Nagata M, Oohira Y, Yamochi T, Fukagai T.   +9 more
europepmc   +1 more source

Comprehensive Profiling Reveals Sialyl-Tn Upregulation and Prognostic Value in Prostate Cancer. [PDF]

Pathol Int
Hodgson K, Blencoe L, Smith E, Sasikumar A, Peng Z, Orozco-Moreno M, Beatson R, Videira PA, Munkley J.   +8 more
europepmc   +1 more source

IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities. [PDF]

Front Immunol
Zhou T, Li Y, Liu Z, Zeng Z, Li T, Chen L, Zhao H, Wu X, Shen Y, Fan H, Zhu X, Zhou Y, Zou L, Zhao D.   +13 more
europepmc   +1 more source

HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. [PDF]

J Exp Clin Cancer Res
Duong QH, Le TK, Tran TT, Audebert S, Camoin L, Nguyen NG, Baboudjian M, Giusiano S, Phan UTT, Zaghdoudi S, Adelaide J, Baylot V, Gleave M, Garrido C, Taïeb D, Rocchi P.   +15 more
europepmc   +1 more source

Circulating Tumor DNA Genomic Profiling in ²²³Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. [PDF]

J Nucl Med
Shiota M, Fujiwara M, Sumiyoshi T, Enokida H, Kamba T, Igawa T, Masumori N, Uemura H, Kamoto T, Higashijima K, Mitsunari K, Uemura H, Kobayashi T, Akamatsu S, Tokunaga S, Isoda T, Ishigami K, Eto M.   +17 more
europepmc   +1 more source

Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94). [PDF]

Int J Urol
Sasaki T, Igarashi A, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Yamasaki T, Inoue T.   +18 more
europepmc   +1 more source